eIF3f: A central regulator of the antagonism atrophy/hypertrophy in skeletal muscle - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue International Journal of Biochemistry and Cell Biology Année : 2013

eIF3f: A central regulator of the antagonism atrophy/hypertrophy in skeletal muscle

Résumé

The eukaryotic initiation factor 3 subunit f (eIF3f) is one of the 13 subunits of the translation initiation factor complex eIF3 required for several steps in the initiation of mRNA translation. In skeletal muscle, recent studies have demonstrated that eIF3f plays a central role in skeletal muscle size maintenance. Accordingly, eIF3f overexpression results in hypertrophy through modulation of protein synthesis via the mTORC1 pathway. Importantly, eIF3f Was described as a target of the E3 ubiquitin ligase MAFbx/atrogin-1 for proteasome-mediated breakdown under atrophic conditions. The biological importance of the MAFbx/atrogin-1-dependent targeting of eFI3f is highlighted by the finding that expression of ad eIF3f mutant insensitive to MAFbx/atrogin-1 polyubiquitination is associated with enhanced protection against starvation-induced muscle atrophy. A better understanding of the precise role of this subunit should lead to the development of new therapeutic approaches to prevent or limit muscle wasting that prevails in numerous physiological and pathological states such as immobilization, aging, denervated conditions, neuromuscular diseases, AIDS, cancer, diabetes. This article is part of a Directed Issue entitled: Molecular basis of muscle wasting. (C) 2013 Elsevier Ltd. All rights reserved.

Dates et versions

hal-01837562 , version 1 (12-07-2018)

Identifiants

Citer

Anthony Sanchez, Alfredo Csibi, Audrey Raibon, Aurélie Docquier, Julie Lagirand, et al.. eIF3f: A central regulator of the antagonism atrophy/hypertrophy in skeletal muscle. International Journal of Biochemistry and Cell Biology, 2013, 45 (10), pp.2158 - 2162. ⟨10.1016/j.biocel.2013.06.001⟩. ⟨hal-01837562⟩
36 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More